Deutsche Bank’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Sell |
736,927
-19,480
| -3% | -$91K | ﹤0.01% | 1411 |
|
|
2025
Q1 | $4.15M | Buy |
756,407
+628,807
| +493% | +$3.45M | ﹤0.01% | 1328 |
|
|
2024
Q4 | $433K | Buy |
127,600
+48,068
| +60% | +$163K | ﹤0.01% | 2650 |
|
|
2024
Q3 | $227K | Buy |
79,532
+24,231
| +44% | +$69.1K | ﹤0.01% | 2828 |
|
|
2024
Q2 | $124K | Sell |
55,301
-13,242
| -19% | -$29.8K | ﹤0.01% | 3007 |
|
|
2024
Q1 | $151K | Buy |
68,543
+2,464
| +4% | +$5.45K | ﹤0.01% | 2933 |
|
|
2023
Q4 | $155K | Sell |
66,079
-2,002
| -3% | -$4.71K | ﹤0.01% | 2959 |
|
|
2023
Q3 | $127K | Buy |
68,081
+10,203
| +18% | +$19K | ﹤0.01% | 3026 |
|
|
2023
Q2 | $152K | Sell |
57,878
-30,977
| -35% | -$81.2K | ﹤0.01% | 3037 |
|
|
2023
Q1 | $145K | Buy |
88,855
+30,231
| +52% | +$49.3K | ﹤0.01% | 3157 |
|
|
2022
Q4 | $78K | Buy |
58,624
+883
| +2% | +$1.17K | ﹤0.01% | 3419 |
|
|
2022
Q3 | $90K | Sell |
57,741
-8,839
| -13% | -$13.8K | ﹤0.01% | 3350 |
|
|
2022
Q2 | $102K | Buy |
+66,580
| New | +$102K | ﹤0.01% | 3491 |
|
|
2021
Q2 | – | Sell |
-99,860
| Closed | -$451K | – | 4631 |
|
|
2021
Q1 | $451K | Buy |
99,860
+64,829
| +185% | +$293K | ﹤0.01% | 3151 |
|
|
2020
Q4 | $172K | Buy |
35,031
+9,259
| +36% | +$45.5K | ﹤0.01% | 3489 |
|
|
2020
Q3 | $153K | Buy |
25,772
+5,857
| +29% | +$34.8K | ﹤0.01% | 3309 |
|
|
2020
Q2 | $53K | Buy |
19,915
+6,298
| +46% | +$16.8K | ﹤0.01% | 3732 |
|
|
2020
Q1 | $27K | Buy |
13,617
+3,942
| +41% | +$7.82K | ﹤0.01% | 3730 |
|
|
2019
Q4 | $67K | Buy |
9,675
+2,136
| +28% | +$14.8K | ﹤0.01% | 3712 |
|
|
2019
Q3 | $73K | Sell |
7,539
-12,682
| -63% | -$123K | ﹤0.01% | 3643 |
|
|
2019
Q2 | $229K | Sell |
20,221
-14,357
| -42% | -$163K | ﹤0.01% | 3671 |
|
|
2019
Q1 | $346K | Buy |
34,578
+27,874
| +416% | +$279K | ﹤0.01% | 3611 |
|
|
2018
Q4 | $112K | Sell |
6,704
-8,312
| -55% | -$139K | ﹤0.01% | 4025 |
|
|
2018
Q3 | $263K | Buy |
+15,016
| New | +$263K | ﹤0.01% | 4025 |
|